Ingredion Incorporated (NYSE:INGR – Get Free Report) Director David Fischer sold 1,662 shares of Ingredion stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $102.31, for a total transaction of $170,039.22. Following the sale, the director owned 19,930 shares of the company’s stock, valued at approximately $2,039,038.30. This represents a 7.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Ingredion Stock Performance
Shares of INGR stock opened at $104.24 on Friday. The firm’s 50 day moving average price is $99.98 and its 200-day moving average price is $108.10. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.83 and a current ratio of 2.80. Ingredion Incorporated has a one year low of $94.44 and a one year high of $130.48. The firm has a market cap of $6.57 billion, a P/E ratio of 11.37, a P/E/G ratio of 0.89 and a beta of 0.62.
Ingredion (NYSE:INGR – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $2.82 earnings per share for the quarter, beating the consensus estimate of $2.71 by $0.11. The firm had revenue of $1.85 billion during the quarter, compared to the consensus estimate of $1.83 billion. Ingredion had a net margin of 8.21% and a return on equity of 15.40%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the firm earned $2.87 EPS. Ingredion has set its FY 2026 guidance at 10.300-10.900 EPS. As a group, equities research analysts predict that Ingredion Incorporated will post 10.6 EPS for the current year.
Ingredion Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on INGR shares. Benchmark reiterated a “buy” rating on shares of Ingredion in a report on Tuesday, June 9th. Oppenheimer cut Ingredion from an “outperform” rating to a “market perform” rating in a report on Monday, June 8th. UBS Group lifted their target price on Ingredion from $104.00 to $108.00 and gave the company a “neutral” rating in a research report on Wednesday. Zacks Research upgraded shares of Ingredion from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 14th. Finally, Barclays reduced their price target on shares of Ingredion from $120.00 to $118.00 and set an “equal weight” rating on the stock in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $121.29.
Read Our Latest Analysis on INGR
Institutional Trading of Ingredion
A number of large investors have recently modified their holdings of the stock. International Assets Investment Management LLC purchased a new position in Ingredion in the fourth quarter valued at $30,000. GHP Investment Advisors Inc. purchased a new stake in Ingredion during the 1st quarter worth about $33,000. Los Angeles Capital Management LLC acquired a new stake in Ingredion in the 4th quarter valued at about $36,000. Capital Advisors Ltd. LLC raised its position in Ingredion by 40.5% in the 4th quarter. Capital Advisors Ltd. LLC now owns 354 shares of the company’s stock valued at $39,000 after purchasing an additional 102 shares in the last quarter. Finally, Bell Investment Advisors Inc purchased a new position in shares of Ingredion in the 2nd quarter valued at about $34,000. Hedge funds and other institutional investors own 85.27% of the company’s stock.
Ingredion Company Profile
Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.
The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.
Recommended Stories
- Five stocks we like better than Ingredion
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.
